Test Directory
Browse our comprehensive catalog of genetic tests
Comprehensive Detoxification & Immunogenetic Risk Panel
This panel integrates key Phase II detoxification genes with critical immune regulation markers, offering a holistic view of how genetic variation influences toxin clearance, drug metabolism, cancer susceptibility, and autoimmune risk. It is designed for clinicians, researchers, and wellness programs seeking actionable insights into both metabolic resilience and immune predisposition
Rare-DiseasesFamilial Variant Testing
Targeted genetic testing focuses on analyzing a specific genetic variant already identified in a patient or family member, and is most often used for cascade testing of at‑risk relatives, carrier testing to assess reproductive risk, confirmatory testing to validate a known finding, and mosaic variant analysis when partial variant presence is suspected.
Rare-DiseasesFamilial Variant Testing
Targeted genetic testing focuses on analyzing a specific genetic variant already identified in a patient or family member, and is most often used for cascade testing of at‑risk relatives, carrier testing to assess reproductive risk, confirmatory testing to validate a known finding, and mosaic variant analysis when partial variant presence is suspected.
Rare-DiseasesHaemophilia A (Intron 22 & I Inversion reflex to Sequencing)
Detection of the common F8 intron 22 and intron 1 inversions, the most frequent pathogenic rearrangements causing severe Haemophilia A. Testing is performed using PCR-based inversion analysis, with MLPA (Multiplex Ligation-dependent Probe Amplification) used to detect exon-level deletions and duplications within the F8 gene. This assay assists in the molecular diagnosis of Haemophilia A and carrier testing in at-risk individuals.
Rare-Diseases